Becker's Payer Flags Four Lingering Operational Questions as CMS Launches the Medicare GLP-1 Bridge: Cost Projections Not Confirmed on Launch Call, Enrollment Forecasts Remain Informal, No Formal Appeals Process, Manufacturer-Negotiated Pricing Details Not Fully Disclosed
Becker's Payer Issues published a launch-day analysis titled '4 questions linger as CMS launches the Medicare GLP-1 Bridge' identifying operational uncertainties in the program even as the first prescriptions begin flowing. The four questions: (1) CMS could not confirm cost or enrollment projections on the launch call, leaving analyst modeling of program cost dependent on informal expectations from CMS Medicare Director Chris Klomp; (2) how quickly enrollment will build past Klomp's 'single-digit millions' framing given the manual prior-authorization workflow; (3) the absence of a formal appeals process within the Bridge itself (providers can resubmit eligibility forms repeatedly but there is no defined appeals track for denied prior authorizations); (4) whether manufacturer-negotiated pricing arrangements will hold at the $245 net price if utilization runs above expectations. The Bridge bypasses Part D sponsors entirely, in contrast to the voluntary Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) Model launching January 2027 in Part D, which required sponsors to sign on. The Bridge's central-processor architecture through Humana handles all payment and prior-authorization traffic outside the standard Part D benefit structure.